Celularity (CELU) EBIT (QoQ) (2019 - 2025)
Powered by 
Analysis
Celularity (CELU) EBIT (QoQ) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.35 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Celularity | 36.65 Mn | 30.48 Mn | -3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -70.99% |
| Sep 30, 2025 | 18.68% |
| Jun 30, 2025 | -51.29% |
| Mar 31, 2025 | -13.00% |
| Dec 31, 2024 | 19.49% |
| Sep 30, 2024 | -13.29% |
| Jun 30, 2024 | -37.95% |
| Mar 31, 2024 | -155.40% |
| Dec 31, 2023 | 113.41% |
| Sep 30, 2023 | -133.68% |
| Jun 30, 2023 | 33.50% |
| Mar 31, 2023 | -465.28% |
| Dec 31, 2022 | 409.69% |
| Sep 30, 2022 | -235.23% |
| Jun 30, 2022 | 110.03% |
| Mar 31, 2022 | -178.34% |
| Dec 31, 2021 | -237.19% |
| Sep 30, 2021 | 117.98% |
| Jun 30, 2021 | -36.53% |
| Mar 31, 2021 | -501.58% |